+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast 2025-2030- Product Image
mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055092
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA vaccines market stands at the forefront of advanced immunotherapy, driven by continued progress in innovative technologies, adaptive manufacturing, and strategic collaborations across global pharmaceutical leaders. Senior decision-makers seeking strategic foresight require actionable analysis to navigate evolving opportunities and overcome newly emerging complexities.

Market Snapshot: mRNA Vaccines Market Growth and Outlook

The mRNA vaccines market grew from USD 9.32 billion in 2024 to USD 10.40 billion in 2025. It is expected to continue growing at a CAGR of 11.86%, reaching USD 18.28 billion by 2030. This robust growth is anchored by technological advances, scalable manufacturing, and expanding therapeutic applications. The market is strategically positioned to serve growing demand across both established and emerging healthcare domains.

Scope & Segmentation

  • Technology Types: Lipid Nanoparticle (LNP) platforms, nucleoside-modified mRNA technologies, self-amplifying mRNA platforms.
  • Routes of Administration: Inhalable mRNA vaccines, injectable formats, oral delivery systems.
  • Manufacturing Processes: Cell-free synthesis, in vitro transcription.
  • Vaccine Classifications: Preventive vaccines, therapeutic vaccines.
  • Application Areas: Cardiovascular disorders, oncology, infectious diseases (including COVID-19 and influenza), genetic disorders (e.g., cystic fibrosis, sickle cell disease).
  • Distribution Channels: Hospital pharmacies, retail pharmacies.
  • Geographies Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including Germany, France, United Kingdom, Switzerland, South Africa, Saudi Arabia, others), Asia-Pacific (China, India, Japan, Australia, South Korea, and Southeast Asian markets).
  • Company Coverage: Analysis includes leading innovators such as Moderna, BioNTech, Pfizer, CureVac, Arcturus, GlaxoSmithKline, Novartis, Sanofi, and more across key biopharma segments.

Key Takeaways for Decision-Makers

  • Rapid platform innovation has accelerated the shift toward next-generation mRNA vaccine candidates addressing both infectious and non-infectious disease targets.
  • Manufacturers are investing in modular and distributed facilities to enhance operational agility and regional supply resilience.
  • Strategic alliances, including joint ventures and licensing agreements, are shortening development timelines and expanding access to new markets.
  • Emergence of inhalable and oral formulation research is reshaping delivery modality strategies to improve patient adherence and accessibility.
  • Workforce upskilling and targeted talent acquisition are crucial to sustaining specialized expertise needed for complex bioengineering and scale-up challenges.
  • Regional policy frameworks and partnership models are influencing technology transfer and capacity building, especially in emerging markets and resource-constrained geographies.

Tariff Impact: Navigating US Trade Policies in 2025

The introduction of new US tariff schedules in early 2025 affects key supply chain components for mRNA vaccines, including lipid nanoparticle ingredients, modified nucleotides, and essential enzymes. These tariffs are driving higher input costs and longer lead times, compelling manufacturers to refine sourcing strategies, expand domestic production, and renegotiate supplier agreements. Industry stakeholders are intensifying process optimization and advocating for policy alignment to protect public health priorities amid shifting trade environments.

Methodology & Data Sources

This research applies a multi-layered methodology, combining in-depth secondary analysis with primary interviews from leaders across biotechnology and pharmaceutical organizations. Data sources include regulatory filings, peer-reviewed publications, investor reports, and insights triangulated through consultations with domain experts and industry executives. Rigorous validation ensures evidence-based insights support strategic decision-making.

Why This Report Matters

  • Enables senior leaders to benchmark technology roadmaps and operational priorities within a rapidly evolving global mRNA vaccines market.
  • Delivers clarity on emerging tariffs, regulatory strategies, and collaborative business models affecting supply chains and competitive positioning.
  • Provides actionable segmentation, trend analysis, and company profiles that inform investment, partnership, and go-to-market strategies.

Conclusion

The mRNA vaccines market is evolving with new platforms, delivery techniques, and global collaborations. Organizations that adapt to changing regulatory, manufacturing, and strategic landscapes will be best positioned for sustained leadership and growth.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of mRNA technology into personalized oncology vaccines enabled by novel neoantigen targeting
5.2. Strategic alliances between biotech firms and CMOs to scale mRNA vaccine manufacturing capacity worldwide
5.3. Emergence of thermostable mRNA formulations reducing cold chain dependency for global vaccine distribution
5.4. Regulatory fast track approvals and adaptive licensing frameworks accelerating next generation mRNA vaccines
5.5. Integration of artificial intelligence in mRNA sequence optimization to shorten development timelines and costs
5.6. Expansion of self-amplifying mRNA platforms to drive lower dose requirements and wider therapeutic applications
5.7. Increased investment flows and public private partnerships fueling global mRNA vaccine pipeline diversification
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Vaccines Market, by Technology Type
8.1. Introduction
8.2. Lipid Nanoparticle (LNP) Platforms
8.3. Nucleoside-Modified mRNA Technologies
8.4. Self-Amplifying mRNA Platforms
9. mRNA Vaccines Market, by Route of Administration
9.1. Introduction
9.2. Inhalable mRNA Vaccines
9.3. Injectable mRNA Vaccines
9.4. Oral Delivery System
10. mRNA Vaccines Market, by Manufacturing Process
10.1. Introduction
10.2. Cell-Free Synthesis
10.3. In Vitro Transcription
11. mRNA Vaccines Market, by Vaccine Classification
11.1. Introduction
11.2. Preventive Vaccines
11.3. Therapeutic Vaccines
12. mRNA Vaccines Market, by Application Areas
12.1. Introduction
12.2. Cardiovascular Disorders
12.3. Genetic Disorders
12.3.1. Cystic Fibrosis Treatments
12.3.2. Sickle Cell Disease mRNA Approaches
12.4. Infectious Diseases
12.4.1. COVID-19 Vaccines
12.4.2. Influenza mRNA Vaccines
12.5. Oncology
13. mRNA Vaccines Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Retail Pharmacies
14. Americas mRNA Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa mRNA Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific mRNA Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Acuitas Therapeutics Inc.
17.3.2. Alnylam Pharmaceuticals, Inc.
17.3.3. Arcturus Therapeutics Holdings Inc.
17.3.4. AstraZeneca PLC
17.3.5. Bavarian Nordic AS
17.3.6. BioNTech SE
17.3.7. Chongqing Zhifei Biological Products Co.,Ltd.
17.3.8. CureVac N.V.
17.3.9. Daiichi Sankyo Company, Limited
17.3.10. Eli Lilly and Company
17.3.11. Ethris GmbH
17.3.12. GlaxoSmithKline PLC
17.3.13. Inovio Pharmaceuticals, Inc.
17.3.14. Johnson & Johnson Services, Inc.
17.3.15. Merck & Co., Inc.
17.3.16. Moderna Inc.
17.3.17. Novartis AG
17.3.18. Pfizer Inc.
17.3.19. Regeneron Pharmaceuticals, Inc.
17.3.20. Roche Holding AG
17.3.21. Sanofi S.A.
17.3.22. Sinovac Biotech Ltd.
17.3.23. Takeda Pharmaceutical Company Limited
17.3.24. Thermo Fisher Scientific Inc.
17.3.25. Vertex Pharmaceuticals Incorporated
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. MRNA VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MRNA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MRNA VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MRNA VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MRNA VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MRNA VACCINES MARKET: RESEARCHAI
FIGURE 28. MRNA VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 29. MRNA VACCINES MARKET: RESEARCHCONTACTS
FIGURE 30. MRNA VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MRNA VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MRNA VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY LIPID NANOPARTICLE (LNP) PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MRNA VACCINES MARKET SIZE, BY LIPID NANOPARTICLE (LNP) PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA VACCINES MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MRNA VACCINES MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA VACCINES MARKET SIZE, BY SELF-AMPLIFYING MRNA PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MRNA VACCINES MARKET SIZE, BY SELF-AMPLIFYING MRNA PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA VACCINES MARKET SIZE, BY INHALABLE MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MRNA VACCINES MARKET SIZE, BY INHALABLE MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA VACCINES MARKET SIZE, BY INJECTABLE MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MRNA VACCINES MARKET SIZE, BY INJECTABLE MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA VACCINES MARKET SIZE, BY ORAL DELIVERY SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MRNA VACCINES MARKET SIZE, BY ORAL DELIVERY SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA VACCINES MARKET SIZE, BY CELL-FREE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MRNA VACCINES MARKET SIZE, BY CELL-FREE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA VACCINES MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MRNA VACCINES MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MRNA VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MRNA VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MRNA VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MRNA VACCINES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MRNA VACCINES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MRNA VACCINES MARKET SIZE, BY CYSTIC FIBROSIS TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MRNA VACCINES MARKET SIZE, BY CYSTIC FIBROSIS TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MRNA VACCINES MARKET SIZE, BY SICKLE CELL DISEASE MRNA APPROACHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MRNA VACCINES MARKET SIZE, BY SICKLE CELL DISEASE MRNA APPROACHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MRNA VACCINES MARKET SIZE, BY COVID-19 VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MRNA VACCINES MARKET SIZE, BY COVID-19 VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MRNA VACCINES MARKET SIZE, BY INFLUENZA MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MRNA VACCINES MARKET SIZE, BY INFLUENZA MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MRNA VACCINES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MRNA VACCINES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MRNA VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MRNA VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MRNA VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MRNA VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS MRNA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES MRNA VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 106. CANADA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 107. CANADA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 110. CANADA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 111. CANADA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 112. CANADA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 113. CANADA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 114. CANADA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 115. CANADA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MRNA VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. GERMANY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. GERMANY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. GERMANY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 212. GERMANY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 213. GERMANY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. FRANCE MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. FRANCE MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. FRANCE MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 222. FRANCE MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 223. FRANCE MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 228. FRANCE MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 229. FRANCE MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ITALY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. ITALY MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. ITALY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 252. ITALY MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 253. ITALY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 254. ITALY MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 255. ITALY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 256. ITALY MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 257. ITALY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 258. ITALY MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 259. ITALY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 260. ITALY MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 261. ITALY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SPAIN MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. SPAIN MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. SPAIN MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 270. SPAIN MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 271. SPAIN MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 276. SPAIN MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 277. SPAIN MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA MRNA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. DENMARK MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK MRNA VACCINES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. DENMARK MRNA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. DENMARK MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2024 (USD MILLION)
TABLE 332. DENMARK MRNA VACCINES MARKET SIZE, BY MANUFACTURING PROCESS, 2025-2030 (USD MILLION)
TABLE 333. DENMARK MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 334. DENMARK MRNA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 335. DENMARK MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 336. DENMARK MRNA VACCINES MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 337. DENMARK MRNA VACCINES MARKET SIZE, BY GENETIC DISORDERS,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Vaccines market report include:
  • Acuitas Therapeutics Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics Holdings Inc.
  • AstraZeneca PLC
  • Bavarian Nordic AS
  • BioNTech SE
  • Chongqing Zhifei Biological Products Co.,Ltd.
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited
  • Eli Lilly and Company
  • Ethris GmbH
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Moderna Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Vertex Pharmaceuticals Incorporated

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.4 billion
Forecasted Market Value ( USD ) by 2030 $ 18.28 billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

mRNA Vaccine Drugs Development Services Market by Service Type, Platform Type, Delivery Technology, Therapeutic Area, End User, Manufacturing Scale - Global Forecast 2025-2030 - Product Image

mRNA Vaccine Drugs Development Services Market by Service Type, Platform Type, Delivery Technology, Therapeutic Area, End User, Manufacturing Scale - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
mRNA Vaccines and Therapeutics Market Report by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2025-2033 - Product Image

mRNA Vaccines and Therapeutics Market Report by Vaccine Type, Treatment Type, Vaccine Manufacturing, Application, End-User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
mRNA Vaccine Raw Materials Market by Material Type (Buffers, Capping Enzymes, Lipids), Delivery System (Exosome Based, Lipid Nanoparticles, Peptide Based), Process Stage, End Use, Application - Global Forecast 2025-2030 - Product Image

mRNA Vaccine Raw Materials Market by Material Type (Buffers, Capping Enzymes, Lipids), Delivery System (Exosome Based, Lipid Nanoparticles, Peptide Based), Process Stage, End Use, Application - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions - Product Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

  • Report
  • 343 Pages
  • Global
From
mRNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

mRNA Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From

About the mRNA Vaccines Market

In the landscape of vaccines, mRNA (messenger RNA) vaccines represent a novel technology that has garnered substantial attention for its role in rapid vaccine development. These vaccines operate by instructing cells to produce a protein that triggers an immune response without using a live virus. This innovative approach stands out for its ability to be developed and scaled up swiftly in response to infectious diseases, offering a flexible platform for vaccine creation. While traditional vaccine development may take years of research and testing, mRNA vaccines can be designed once the genetic information of a pathogen is known. The adoption of mRNA vaccines has been driven by their potential to address a broad spectrum of diseases beyond just infectious agents. Research is being conducted into their applicability in treating and preventing cancers, genetic disorders, and autoimmune diseases. This expansion of mRNA technology into various medical domains has contributed to the diversification of the vaccine industry. Several prominent companies are active in the mRNA vaccines market, shaping its trajectory with their research and development efforts. Notable firms include Moderna, Pfizer in collaboration with BioNTech, and CureVac. These companies have invested heavily in mRNA technology, leading to advances that have solidified their positions as key players in the pharmaceutical and biotechnology sectors. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.